$RVPH

$0.35 +$0.00 (0.0%) Close

$RVPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 13.1M shares outstanding

Who owns RVPH?

By type of holder

Institutions 0.1% Everyone else 99.9%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 7 holders own 30.9%

Bhat Laxminarayan 28.1% · Parag Saxena 2.8%

Institutional ownership

0.1%

-22.2 pts vs last qtr

Institutional holders

-30 vs last qtr

Net shares bought

−2.9M

by institutions in Q2 2026

New / sold out

3 / 33

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

EMC Capital Management NEW +6.7K
Miller Global Investments, LLC NEW +1

Biggest sellers in Q2 2026

Millennium Management LLC SOLD OUT −793.9K
Highbridge Capital Management LLC SOLD OUT −762.2K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Reviva Pharmaceuticals Holdings Inc in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Reviva Pharmaceuticals Holdings Inc.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years8% Under 1 year92%

Quarterly turnover

50.1%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting RVPH on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MM Millennium Management LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding2.3M (Q4'25) Change over 8 quarters−1.8M Millennium Management LLC's full portfolio →
HC Highbridge Capital Management LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding762.2K (Q1'26) Change over 8 quarters0 Highbridge Capital Management LLC's full portfolio →

Millennium Management LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

Highbridge Capital Management LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

8 more super investors behind a free account

See every manager holding Reviva Pharmaceuticals Holdings Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting RVPH on Form N-PORT; together they hold 9.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$118K	548.5K	4.18%	0.00%	February 28, 2026
FT Fidelity Total Market Index Fund Fidelity Concord Street Trust	$46.5K	216.7K	1.65%	0.00%	February 28, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$118K

% of company

4.18%

% of the fund

0.00%

As of

February 28, 2026

Fidelity Total Market Index Fund

Fidelity Concord Street Trust

Position value

$46.5K

% of company

1.65%

% of the fund

0.00%

As of

February 28, 2026

8 more funds behind a free account

See every fund holding Reviva Pharmaceuticals Holdings Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BL Bhat Laxminarayan 5%+ holder 13D · 3.8%	3.7M	28.08%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company28.080% Disclosed stake13D · 3.8% View the 13D/G filing →
PS Parag Saxena 5%+ holder 13D · 2.8%	363.3K	2.77%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company2.770% Disclosed stake13D · 2.8% View the 13D/G filing →

Bhat Laxminarayan

5%+ holder13D · 3.8%

3.7M

% of company

28.08%

Change vs last qtr

—

Held since

—

Parag Saxena

5%+ holder13D · 2.8%

363.3K

% of company

2.77%

Change vs last qtr

—

Held since

—

Comments